Inogen INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Inogen, Inc. reported a significant reduction in net loss for fiscal year 2025, driven by increased international sales and strategic product portfolio expansion.
NASDAQ
Inogen's 2024 10-K filing reveals a 6.4% increase in total revenue, driven by a surge in international and domestic business-to-business sales, alongside strategic shifts in management and product development.
NASDAQ
Physio-Assist has appointed Grgoire Ramade as Chief Commercial Officer, modifying his previous role as Senior Vice-President of International Sales.